sprite-preloader
Donnerstag, 24.07.2014 Börsentäglich über 12.000 News von 479 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: A1J84E ISIN: US00287Y1091 Ticker-Symbol: 4AB 
Aktie:
Branche
Pharma
Aktienmarkt
S&P 100
S&P 500
1-Jahres-Chart
ABBVIE INC Chart 1 Jahr
1-Woche-Intraday-Chart
ABBVIE INC 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
40,11
40,17
19:44
40,07
40,21
19:44

Aktuelle News zu ABBVIE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
ABBVIE Aktie jetzt ab 5 Dollar handeln!

► Artikel lesen
18:32Obama administration putting heft behind tax inversion legislation that could apply to AbbVie-Shire deal-

► Artikel lesen
16:39Form 8.3 - Abbvie Inc1
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the...
► Artikel lesen
15:41Form 8.3 - AbbVie Inc1
-FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the...
► Artikel lesen
15:31The Zacks Analyst Blog Highlights: Biogen Idec, Roche Holding, AbbVie, AmSurg and Acadia Healthcare3
CHICAGO, July 24, 2014 /PRNewswire/ --Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting...
► Artikel lesen
15:31The Zacks Analyst Blog Highlights: AbbVie, Shire, Amgen, InterMune and Biogen6
CHICAGO, July 24, 2014 /PRNewswire/ --Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting...
► Artikel lesen
07:12ABBVIE: AbbVie to Host Second-Quarter Earnings Conference Call 2

► Artikel lesen
MiBiotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 37

► Artikel lesen
MiAbbVie to Host Second-Quarter Earnings Conference Call4
NORTH CHICAGO, Ill., July 23, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD...
► Artikel lesen
MiForm 8.3 - Abbvie Inc3
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the...
► Artikel lesen
MiPentwater Capital Management LP - Form 8.3 - AbbVie Inc3
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES...
► Artikel lesen
MiForm 8.3 - AbbVie Inc.2
-FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the...
► Artikel lesen
MiForm 8.3 - AXA INVESTMENT MANAGERS S.A.: ABBVIE INC2
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1.         KEY INFORMATION+-------------------------------------------------+----------------------------+ |(a)...
► Artikel lesen
MiShire inks a $225M rare disease deal on the eve of life with AbbVie5

► Artikel lesen
DiShire's Q2 Earnings Strong but Overshadowed by AbbVie Deal9

► Artikel lesen
DiForm 8.3 - Abbvie Inc2
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the...
► Artikel lesen
DiForm 8.3 - AbbVie Inc.1
-FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the...
► Artikel lesen
DiHere's What You Need to Know About AbbVie and GlaxoSmithKline's Upcoming Earnings9

► Artikel lesen
DiÜbernahme spart Abbvie Steuer-Milliarden10

► Artikel lesen
MoForm 8.3 - ABBVIE INC3
FORM 8.3  **AMENDMENT** PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE ...
► Artikel lesen
MoWelcome to Ireland, AbbVie11

► Artikel lesen
Seite:  Weiter >>
727 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
ABBVIE INC-Investoren interessieren sich auch für diese News

Unternehmen / AktienAktienkurs%Top-Nachrichten
GILEAD SCIENCES67,54+1,38 %Gilead - Durchstarten mit neuem Produkt
Gilead - Durchstarten mit neuem Produkt Gilead Sciences ist ein biopharmazeutisches Unternehmen, das innovative Arzneimittel für medizinischen Bedarf entwickelt...
► Artikel lesen
ABBOTT LABORATORIES31,762-0,25 %Abbott Introduces New Similac Breastfeeding Supplement with DHA, Lutein and Vitamin E
ABBOTT PARK, Ill., July 24, 2014 /PRNewswire/ -- Nutrition needs are greater when breastfeeding than any other time in a woman's life, including pregnancy, yet new research reveals diet alone may...
► Artikel lesen
NOVO NORDISK33,945-1,59 %Global Type 1 Diabetes Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Co, Novo Nordisk and Sanofi-Aventis
DUBLIN, July 18, 2014 /PRNewswire/ -- Research and Markets(http://www.researchandmarkets.com/research/3txjqf/global_type_1) has announced the addition of the"Global Type 1 Diabetes Market 2014-2018"report...
► Artikel lesen
STADA ARZNEIMITTEL32,295+0,70 %Aus anderen Finanzblogs - KW30/2014 u.a. mit Apple, Heidelberger Druck, Scotiabank, Stada, SMI, Anglo American
Der Blick in andere Blogs und Wirtschaftspublikationen. Das schreiben die Kollegen: Einzelwerte Apple, das nach Börsenwert wertvollste Technologieunternehmen der Welt, hat gestern Quartalszahlen vorgelegt....
► Artikel lesen
NOVARTIS66,25+0,49 %dpa-AFX Überblick: ANALYSTEN-EINSTUFUNGEN vom 17.07.2014: ADIDAS, AIR LIQUIDE, AIRBUS, AURUBIS, AXA, BARCLAYS, BASF, BEIERSDORF, BHP BILLITON, BMW, BP, BRITISH AMERICAN TOBACCO, BSKYB, CARREFOUR, COMDIRECT ...
Ausgewählte Analysten-Einstufungen im dpa-AFX-Nachrichtendienst vom 17.07.2014 ADIDAS PARIS - Die französische Investmentbank Exane BNP Paribas hat das Kursziel für Adidas von 94 auf 90 Euro...
► Artikel lesen
Lade...